Capitale Sociale E Riserve Cambiamento Data
Cara Therapeutics USD 20.95M 6.92M 2025-12
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
Cronos Group USD 1.07B 20.24M 2026-03
RedHill Biopharma USD 4.27M 8.68M 2025-12